Covered recipient · General Payments record
RUSSELL D ANDERSON
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$659.78
- Reported across 37 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $182.68 | 8 |
| Education | $74.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Daiichi Sankyo Inc. | $100.11 | 2 |
| Janssen Biotech, Inc. | $73.76 | 3 |
| Celgene Corporation | $45.01 | 2 |
| GlaxoSmithKline, LLC. | $21.07 | 1 |
| ARRAY BIOPHARMA INC | $17.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ARRAY BIOPHARMA INC | $17.72 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131365903 | CMS |
| Celgene Corporation | $24.20 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101136422 | CMS |
| Celgene Corporation | $20.81 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101136426 | CMS |
| Daiichi Sankyo Inc. | $74.99 | 09/25/2024 | Education | Undisputed | 01/23/2026 | 1089393602 | CMS |
| Daiichi Sankyo Inc. | $25.12 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089393608 | CMS |
| GlaxoSmithKline, LLC. | $21.07 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116722659 | CMS |
| Janssen Biotech, Inc. | $33.49 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078328399 | CMS |
| Janssen Biotech, Inc. | $23.31 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078328415 | CMS |
| Janssen Biotech, Inc. | $16.96 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078328435 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.